{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:15:59Z","timestamp":1782782159748,"version":"3.54.5"},"reference-count":27,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cardiovasc electrophysiol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Different ablation strategies have been developed for persistent atrial fibrillation (PeAF), but early management is still controversial. In the clinical setting of PeAF, the safety and efficacy of early Marshall plan have not yet been fully studied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Our prospective cohort study sought to: (1) assess the safety and feasibility of the thermal Marshall plan (MPA) approach as a first\u2010line therapy in PeAF patients; (2) evaluate its long\u2010term sinus rhythm maintenance efficacy; (3) identify the long\u2010term predictive factors of AF recurrence in PeAF patients after MPA approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and Results<\/jats:title><jats:p>Between January 2020 and December 2023, 118 PeAF patients were selected for first intent Marshall plan ablation (MPA). Marshall vein failure occurred in 9\/118 patients (7.6%). Accordingly, 109 patients who underwent MPA as first\u2010line therapy were included. After the blanking period of 3 months, 62\/109 patients were in sinus rhythm (SR) (57%), 33\/109 were in AF (30.2%), 8\/109 were in left atrial flutter (AFL) (7.3%), and six were in right AFL (5.5%). Re\u2010ablation was performed in 4\/33 patients (12.1%) and cardioversion in 29\/33 (87.9%) for patients in AF at 3 months after healing. All patients in AFL at 3 months were re\u2010ablated and all recovered SR. At 12 months postablation, two patients were lost to follow\u2010up (1.8%), 94\/107 (87.8%) were in SR and 13\/107 had AF recurrence (12.2%). At 21\u2009\u00b1\u200911 months postablation, 81\/107 (75.7%) were in SR at the last control, and 26\/107 (24.3%) had AF recurrence. The ablation procedure ratio was 1.17 (109 primo ablation, 18 re\u2010ablation). The only predictive factors of late AF recurrence after first\u2010line PeAF MPA were both left atrial dilatation and low left ventricular ejection fraction (LVEF).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This real\u2010life prospective cohort study showed that de novo MPA in PeAF is feasible, relatively safe, and associated with a high rate of freedom from arrhythmia recurrence during long\u2010term follow\u2010up. The percentage of patients remaining in SR during long\u2010term follow\u2010up was close to 76%. The only predictive MPA failure factors were both left atrial dilatation and low LVEF.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jce.16650","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T17:25:42Z","timestamp":1742837142000},"page":"1244-1252","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["First\u2010Line Marshall Plan Approach in Persistent Atrial Fibrillation: A Prospective Single\u2010Center Cohort Study"],"prefix":"10.1111","volume":"36","author":[{"given":"Antoine","family":"Carmaux","sequence":"first","affiliation":[{"name":"Department of Cardiology Jean Monnet University Saint\u2010Etienne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Yvorel","sequence":"additional","affiliation":[{"name":"Department of Cardiology Jean Monnet University Saint\u2010Etienne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Benali","sequence":"additional","affiliation":[{"name":"Department of Cardiology Jean Monnet University Saint\u2010Etienne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Romeyer","sequence":"additional","affiliation":[{"name":"Department of Cardiology Jean Monnet University Saint\u2010Etienne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayan","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Department of Cardiology Jean Monnet University Saint\u2010Etienne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Vovor","sequence":"additional","affiliation":[{"name":"Department of Cardiology Jean Monnet University Saint\u2010Etienne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3302-9988","authenticated-orcid":false,"given":"Antoine","family":"Da Costa","sequence":"additional","affiliation":[{"name":"Department of Cardiology Jean Monnet University Saint\u2010Etienne France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.05.012"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae176"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw260"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu374"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408288"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.111.966226"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.088"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.10.031"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.12.028"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eux370"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.01.003"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019406"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408288"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.8831"},{"issue":"11","key":"e_1_2_9_16_1","article-title":"Low Voltage Myocardium\u2010Guided Ablation Trial for Persistent Atrial Fibrillation","volume":"1","author":"Huo Y.","year":"2022","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.23722"},{"key":"e_1_2_9_18_1","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24178","article-title":"Efficacy and Feasibility of Vein of Marshall Ethanol Infusion During Persistent Atrial Fibrillation Ablation: A Systematic Review and Meta\u2010Analysis","volume":"47","author":"Ge W.","year":"2023","journal-title":"Clinical Cardiology"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.16195"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2021.01.005"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.871654"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jce.13797"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.12.023"},{"key":"e_1_2_9_24_1","first-page":"513","article-title":"Ethanol Infusion In the Vein of Marshall Is Feasible in Experienced Centers\u2014But Is It Ready for Every Tom, Dick, and Harry?","volume":"66","author":"Knecht S.","year":"2023","journal-title":"Journal of Interventional Cardiac Electrophysiology"},{"issue":"1","key":"e_1_2_9_25_1","first-page":"5","article-title":"Left Atrial Posterior Wall Isolation During Catheter Ablation With the Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation","volume":"26","author":"Schiavone M.","year":"2024","journal-title":"EP Europace"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.121.010001"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.24438"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euq434"}],"container-title":["Journal of Cardiovascular Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jce.16650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T12:47:40Z","timestamp":1749732460000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jce.16650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1111\/jce.16650"],"URL":"https:\/\/doi.org\/10.1111\/jce.16650","archive":["Portico"],"relation":{},"ISSN":["1045-3873","1540-8167"],"issn-type":[{"value":"1045-3873","type":"print"},{"value":"1540-8167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"2024-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}